CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company
ACHIEVE LIFE SCIENCES, INC.
Sign in to watch- Ticker
- ACHV
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 954343413
- Phone
- 425-686-1500
- Business address
- 22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
- Former names
- ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $175,177
- in 1 filing
Net −$175,177. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2012-05-31 | PARKER H STEWART Director | Grant or award · Stock Option (right to buy) | +4,000 | 4,000 | ||
| 2012-05-31 | PARKER H STEWART Director | Grant or award · Restricted Stock Units | +2,000 | 2,000 | ||
| 2012-05-31 | MATTINGLY MARTIN A Director | Grant or award · Stock Option (right to buy) | +4,000 | 4,000 | ||
| 2012-05-31 | MATTINGLY MARTIN A Director | Grant or award · Restricted Stock Units | +2,000 | 2,000 | ||
| 2012-05-31 | GOLDSTEIN JACK Director | Grant or award · Stock Option (right to buy) | +4,000 | 4,000 | ||
| 2012-05-31 | GOLDSTEIN JACK Director | Grant or award · Restricted Stock Units | +2,000 | 2,000 | ||
| 2012-05-31 | Clendeninn Neil James Director | Grant or award · Stock Option (right to buy) | +4,000 | 4,000 | ||
| 2012-05-31 | Clendeninn Neil James Director | Grant or award · Restricted Stock Units | +2,000 | 2,000 | ||
| 2012-05-08 | Cormack Scott Daniel President and CEO | Grant or award · Stock Option (right to buy) | +37,500 | 37,500 | ||
| 2012-05-08 | Cormack Scott Daniel President and CEO | Grant or award · Restricted Stock Units | +18,750 | 18,750 | ||
| 2012-05-08 | Cormack Scott Daniel President and CEO | Grant or award · Restricted Stock Units | +25,000 | 25,000 | ||
| 2012-05-08 | Lawrence Cameron William Principal Accounting Officer | Grant or award · Stock Option (right to buy) | +3,000 | 3,000 | ||
| 2012-05-08 | Lawrence Cameron William Principal Accounting Officer | Grant or award · Restricted Stock Units | +1,500 | 1,500 | ||
| 2012-05-08 | Lawrence Cameron William Principal Accounting Officer | Grant or award · Restricted Stock Units | +3,250 | 3,250 | ||
| 2012-05-08 | JACOBS CINDY EVP, CMO | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2012-05-08 | JACOBS CINDY EVP, CMO | Grant or award · Restricted Stock Units | +7,500 | 7,500 | ||
| 2012-05-08 | JACOBS CINDY EVP, CMO | Grant or award · Restricted Stock Units | +17,500 | 17,500 | ||
| 2012-05-08 | BURRIS MICHELLE CFO | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2012-05-08 | BURRIS MICHELLE CFO | Grant or award · Restricted Stock Units | +7,500 | 7,500 | ||
| 2012-05-08 | BURRIS MICHELLE CFO | Grant or award · Restricted Stock Units | +17,500 | 17,500 |
Page 33 of 36 · 715 trades